Inhibition of KDM1A activity restores adult neurogenesis and improves hippocampal memory in a mouse model of Kabuki syndrome

Li Zhang, Genay Pilarowski, Emilio Merlo Pich, Atsushi Nakatani, John Dunlop, Rina Baba, Satoru Matsuda, Masaki Daini, Yasushi Hattori, Shigemitsu Matsumoto, Mitsuhiro Ito, Haruhide Kimura, Hans Tomas Bjornsson

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

KMT2D and KDM1A have opposing effects on histone 3 lysine 4 methylation. In this study, we show that TAK-418, an inhibitor of KDM1A, rescues abnormal gene expression and chromatin levels as well as defects of adult neurogenesis and hippocampal memory in a mouse model of Kabuki syndrome carrying a mutation in Kmt2d.

Original languageEnglish (US)
Pages (from-to)779-791
Number of pages13
JournalMolecular Therapy - Methods and Clinical Development
Volume20
DOIs
StatePublished - Mar 12 2021

Keywords

  • ERK
  • H3K4me1
  • H3K4me3
  • LSD1
  • adult neurogenesis
  • chromatin
  • epigenetics
  • histone modification
  • splenomegaly
  • therapeutics

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Fingerprint

Dive into the research topics of 'Inhibition of KDM1A activity restores adult neurogenesis and improves hippocampal memory in a mouse model of Kabuki syndrome'. Together they form a unique fingerprint.

Cite this